Date |
Company |
Amount |
Funding type |
Investors |
Therapeutic area |
Type of Information |
2018-05-23 |
Celyad (Belgium) |
$54.4 million (approximately €46.1 million), |
private placement |
|
Cancer - Oncology |
Private placement |
2018-05-16 |
HiFiBiO Therapeutics (USA - MA) |
$37.5 million |
series B financing round |
Sequoia China (China) LYFE Capital (China) VI Ventures (China) Nest.Bio Ventures (USA - MA) Legend Star Capital (China) Proxima Ventures (Israel) |
Technology - Services |
Series B financing round |
2018-05-09 |
IGEM Therapeutics (UK) |
£1.45 million |
grant |
Innovate UK (UK) |
Cancer - Oncology |
Grant |
2018-05-08 |
InflaRX (Germany) |
$62.9 million |
private placement |
|
Inflammatory diseases |
Private placement |
2018-05-07 |
Melinta Therapeutics (USA - CT) |
up to $6.2 million |
grant |
Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB - X) (USA - MA) |
Infectious diseases |
Grant |
2018-05-03 |
Synpromics (UK) |
£1.9 million |
grant |
Scottish Enterprise (UK) |
Technology - Services |
Grant |
2018-04-30 |
Sangamo Therapeutics (USA - CA) |
$230 million |
private placement |
|
Rare diseases - Genetic diseases |
Private placement |
2018-04-27 |
Sangamo Therapeutics (USA - CA) |
$8 million |
grant |
California Institute for Regenerative Medicine (CIRM) (USA - CA) |
Rare diseases - Genetic diseases - Hematological diseases |
Grant |
2018-04-27 |
A-Mansia (Belgium) |
€13 million |
series A financing round |
Seventure (France) Fonds Vives II (Belgium) SRIW Life Sciences (Belgium) Nivelinvest (Belgium) Pierre Drion |
Metabolic diseases |
Series A financing round |
2018-04-26 |
Mereo BioPharma (UK) |
|
IPO |
|
Rare diseases - Genetic diseases |
IPO |
2018-04-19 |
Tmunity Therapeutics (USA - PA) |
$135 million |
series A financing round |
Kleiner Perkins (USA) Ping An Ventures (China) Parker Institute for Cancer Immunotherapy (USA - CA) Gilead Sciences, (USA - CA) Be The Match BioTherapies (USA - MN) University of Pennsylvania (USA - PA) Lilly Asia Ventures (China) |
Cancer - Oncology |
Series A financing round |
2018-04-02 |
ITBMed (Sweden) |
up to $67 million |
financing round |
Royalty Pharma (US - NY) |
Transplantation |
Financing round |
2018-03-27 |
Poietis (France) |
€5 million |
series A financing round, grant |
WiSEED (France) Nouvelle Aquitaine Coinvestment Fund (France) |
Technology - Services |
Series A financing round |
2018-03-15 |
Ideaya Bioscience (USA - CA) |
$94 million |
series B financing round |
BVF Partners (USA - CA) Perceptive Advisors (USA - NY) 6 Dimensions Capital (China) Tavistock Group (Bahamas) Nextech Invest (Switzerland) GV (USA - CA) Roche Venture Fund (Switzerland) 5AM Ventures (USA - CA) Canaan Partners (USA - CA) Celgene (USA - NJ) WuXi Healthcare Ventures (China) Novartis Institute of Biomedical Research -Alexandria Real Estate |
Cancer - Oncology |
Series B financing round |
2018-02-23 |
Fate Therapeutics (USA - CA) |
$4 million |
grant |
California Institute for Regenerative Medicine (CIRM) (USA - CA) |
Cancer - Oncology |
Grant |
2018-02-23 |
Fate Therapeutics (USA - CA) |
$4 million |
grant |
California Institute for Regenerative Medicine (CIRM) (USA - CA) |
Cancer - Oncology |
Grant |
2018-02-16 |
ABAC Therapeutics (Spain) |
€16 million |
series A financing round |
Pontifax (Israel) Quark Venture (Canada) GF Securities (China) Caixa Capital Risc (Spain) Debiopharm Innovation Fund (Switzerland) Ferrer (Spain) |
Infectious diseases |
Series A financing round |
2018-02-07 |
Sangamo Therapeutics (USA - CA) Case Western Research University (USA - OH) |
$11 million |
grant |
National Institutes of Health (NIH) (USA) |
Infectious diseases |
Grant |
2018-02-05 |
Metrion Biosciences (UK) |
£200 000 |
grant |
Innovate UK Biomedical Catalyst Feasibility Award scheme (UK) |
Autoimmune diseases - Neurodegenerative diseases |
Grant |
2018-02-02 |
Viking Therapeutics (USA - PA) |
$55 million |
private placement |
|
Endocrinological diseases - Metabolic diseases |
Private placement |